Elevance Health Trading Volume Drops 43.3% to $290 Million, Ranks 322nd in Daily Volume

On June 27, 2025, Elevance Health (ELV) saw a trading volume of $290 million, marking a 43.3% decrease from the previous day. This placed the company at the 322nd position in terms of trading volume for the day. The stock price of Elevance Health rose by 2.20%.

Elevance Health is set to release its fiscal second-quarter earnings next month, with analysts forecasting a single-digit decline in earnings. This upcoming report is crucial for investors as it will provide insights into the company's financial performance and future outlook.

Elevance Health, Inc. is expected to achieve an earnings per share (EPS) of $33.96 for the current fiscal year, according to sell-side analysts. This projection reflects the company's strong financial health and its ability to generate consistent profits.

Elevance Health reported a net margin of 3.23% and a return on equity of 18.61%, indicating robust financial performance. The company's strong financial metrics are a testament to its effective management and strategic initiatives.

Elevance Health, Inc. reaffirmed its 2025 EPS guidance, projecting earnings between $28.30 and $29.00 per share. This reaffirmation comes despite concerns over Medicare audit issues, demonstrating the company's confidence in its financial outlook.